Abstract Kallmann syndrome (KS) consists of anosmia related to defective olfactory bulb development and hypogonadotrophic hypogonadism due to gonadotrophin‐releasing hormone (GnRH) deficiency. Two genes have been identified so far: KAL‐1 , encoding anosmin‐1, and KAL‐2 ,encoding fibroblast growth factor receptor 1 (FGFR1).